How BPC-157 Works in the Body BPC-157 is a synthetic pentadecapeptide fragment derived from body protective compound found in human gastric juice
BPC-157 upregulates survival genes (Akt1, KRAS, Src, Foxo1), reduces inflammatory mediators (IL-6, TNF-, NOS2, NFB), scavenges reactive oxygen species through its four carboxylic groups, activates vascular bypass pathways, and maintains blood flow despite vessel occlusion
GLP-1 and GIP can decelerate gastric emptying, thus moderating the rate of nutrient absorption and aiding glycemic control
Trial data generally shows: Mounjaro: 15-20% body weight reduction over 12-18 months Ozempic: 10-15% body weight reduction over a similar period If weight is the primary driver not just blood sugar Mounjaros dual-hormone mechanism gives it an edge for most patients
E., OConnor, P